https://orcid.org/0000-0001-5674-7881
References
- Fang H, Tong W, Branham WS, Moland CL, Dial SL, Hong H, Xie Q, Perkins R, Owens W, Sheehan DM. 2003. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol. 16(10):1338–1358.
- Helsen C, Marchand A, Chaltin P, Munck S, Voet A, Verstuyf A, Claessens F. 2012. Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growth. Mol Cancer Ther. 11(6):1257–1268.
- Li X, Wu Q, Xie Y, Ding Y, Du WW, Sdiri M, Yang BB. 2015. Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by up-regulating multiple tumor suppressors. Oncotarget. 6:17832–17846.
- Russo A, Cardile V, Piovano M, Caggia S, Espinoza CL, Garbarino JA. 2010. Pro-apoptotic activity of ergosterol peroxide and (22E)-ergosta-7,22-dien-5alpha-hydroxy-3,6-dione in human prostate cancer cells. Chem Biol Interact. 184(3):352–358.
- Song MJ, Hai-Ying B, Tolgor B, Yu L. 2015. Antitumor activity and structure-activity relationship of four steroids from Fomitiporia ellipsoidea. Mycosystema. 34:293–300.
- Vidal-Limón AM, Luna-Martínez OD, Rojas-Durán F, Meza-Menchaca T, Hernández-Aguilar ME, Trigos Á, Suárez-Medellín J. 2017. Molecular dynamics and virtual screening analysis of lanosterol derivatives from Ganoderma medicinal mushrooms (agaricomycetes) as selective ligands of human androgen receptor. Int J Med Mushrooms. 19(7):595–605.
- Zaidman BZ, Wasser SP, Nevo E, Mahajna J. 2008. Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep. 35(2):107–117.
- Zhang S, Sugawara Y, Chen S, Beelman RB, Tsuduki T, Tomata Y, Matsuyama S, Tsuji I. 2019. Mushroom consumption and incident risk of prostate cancer in Japan: a pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study. Int J Cancer. ijc 1–10. doi: https://doi.org/10.1002/ijc.32591.